DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: LEMTRADA (Campath, alemtuzumab)
       *****************************************************
       #Post#: 2606--------------------------------------------------
       (MS Journal editorial) Emerging safety issues in alemtuzumab-tre
       ated MS patients
       By: agate Date: August 2, 2019, 6:55 pm
       ---------------------------------------------------------
       An editorial with cautions about Lemtrada--"Emerging safety
       issues in alemtuzumab-treated MS patients" in Multiple Sclerosis
       Journal (August 1, 2019):
  HTML https://journals.sagepub.com/doi/full/10.1177/1352458519851219
       *****************************************************